SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites

Saad Saffo; Tamar Taddei

doi:10.1002/cld.714

SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites

Saad Saffo^*, Tamar Taddei

^*Corresponding author for this work

Medicine, Gastroenterology Division

Research output: Contribution to journal › Review article › peer-review

31 Scopus citations

Original language	English (US)
Pages (from-to)	141-144
Number of pages	4
Journal	Clinical Liver Disease
Volume	11
Issue number	6
DOIs	https://doi.org/10.1002/cld.714
State	Published - Jun 2018

ASJC Scopus subject areas

Hepatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cld.714

Cite this

@article{10e427eabfc643ce825d9f22dd767d6e,

title = "SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites",

author = "Saad Saffo and Tamar Taddei",

year = "2018",

month = jun,

doi = "10.1002/cld.714",

language = "English (US)",

volume = "11",

pages = "141--144",

journal = "Clinical Liver Disease",

issn = "2046-2484",

publisher = "John Wiley and Sons Ltd",

number = "6",

}

TY - JOUR

T1 - SGLT2 inhibitors and cirrhosis

T2 - A unique perspective on the comanagement of diabetes mellitus and ascites

AU - Saffo, Saad

AU - Taddei, Tamar

PY - 2018/6

Y1 - 2018/6

UR - http://www.scopus.com/inward/record.url?scp=85050646763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050646763&partnerID=8YFLogxK

U2 - 10.1002/cld.714

DO - 10.1002/cld.714

M3 - Review article

C2 - 30992805

AN - SCOPUS:85050646763

SN - 2046-2484

VL - 11

SP - 141

EP - 144

JO - Clinical Liver Disease

JF - Clinical Liver Disease

IS - 6

ER -

SGLT2 inhibitors and cirrhosis: A unique perspective on the comanagement of diabetes mellitus and ascites

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this